Biotech Investors & VC Firms in United States

564 firms in this list, with a median first check of $500K. 46 of them lead rounds. Generated from verified public data and updated continuously.

Fund	HQ	Invests	Stage	Check	CRM
Catalio Capital Management, LP 11 people	New York	US	Seed–Late Stage	—	+ Add to CRM
Digitalis Ventures 11 people	New York	US	Seed–Late Stage	—	+ Add to CRM
HealthCap 11 people	Stockholm	SE	Seed–Series A	—	+ Add to CRM
Serendipity Impact VC 5 people	New York	US	Seed–Series B	—	+ Add to CRM
TVM Capital 8 people	Munchen	DE	Seed–Late Stage	$1.1M – $16.2M	+ Add to CRM
VantagePoint Capital Partners 8 people	Santa Barbara	US	Seed–Late Stage	$2M – $100M	+ Add to CRM
Cape Fear BioCapital 3 people · Leads rounds	Durham	US	Pre-Seed–Series B	—	+ Add to CRM
Ferocity Capital 3 people	—		—	—	+ Add to CRM
Infotech Ventures	Beijing	CN	Seed–Late Stage	—	+ Add to CRM
Phyto Partners 3 people	Boca Raton	US	Seed–Series A	—	+ Add to CRM
Boston Millennia Partners 7 people	Boston	US	Seed–Late Stage	$3M – $5M	+ Add to CRM
Catalys Pacific 10 people	Tokyo	JP	Seed–Series A	—	+ Add to CRM
Droia Ventures 7 people	Zaventem	BE	Seed–Series A	$540K	+ Add to CRM
EcoR1 Capital 10 people	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
Milano Investment Partners SGR 10 people	Milan	IT	Seed–Late Stage	—	+ Add to CRM
Ocean Azul Partners 7 people	Coral Gables	US	Seed–Series A	$500K – $2M	+ Add to CRM
Pivotal Life Sciences 10 people	San Francisco	US	Seed–Late Stage	—	+ Add to CRM
Sutter Hill Ventures 3 people	Palo Alto	US	Seed–Late Stage	$100K – $5M	+ Add to CRM
Carbon Silicon	Carson City	US	—	—	+ Add to CRM
Crede CapitalGroup Follows rounds	Los Angeles	US	—	$5M – $50M	+ Add to CRM
Dynamk Capital 3 people	New York	US	Seed–Series B	—	+ Add to CRM
Corner Ventures 8 people	New York	US	Seed–Late Stage	—	+ Add to CRM
LifeSci Venture Partners 2 people	New York	US	Series A–Late Stage	—	+ Add to CRM
Forbion 1 person	Amsterdam	NL	Pre-Seed–Late Stage	—	+ Add to CRM